Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness.
Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly to the site of implantation. The study, led by researchers at Case Western Reserve University (CWRU) in collaboration with Haima Therapeutics, has the potential to treat a wide range of inflammatory diseases and improve devices that let people control prosthetic limbs with their thoughts.
Nanoparticles as a Trojan horse
The team used a novel ‘platelet-inspired nanoparticle’ to transport an anti-inflammatory drug directly to the brain where BCI electrodes are implanted, which doubled the effectiveness of the electrodes.
“When we implant devices in the brain, it disrupts the blood-brain barrier, and we knew platelets would be showing up to seal the breach,” said neural engineer Andrew Shoffstall, the Nord Distinguished Associate Professor of Biomedical Engineering in the Case School of Engineering and Case Western Reserve School of Medicine. “We used these nanoparticles that act like platelets as a Trojan horse to target the site where we’re putting the device.”
How brain-computer interfaces work
BCI technology allows people with spinal cord injuries or prosthetic limbs to operate devices or limbs by thinking about them. Electrodes implanted in the brain sense neuronal activity and translate it into commands. However, inflammation around the implants can interfere with signals, limiting the lifespan and effectiveness of the electrodes.
By delivering the drug directly using nanoparticles, the team improved electrode performance.
“The brain recognises the implant as a foreign object – like a splinter – and it responds with inflammation to try to isolate and neutralise it,” Shoffstall explained.
By delivering the drug directly using nanoparticles, the team improved electrode performance, whereas administering the same drug systemically actually worsened results. The team now plans to move the research towards translation, starting with safety studies.
Synthetic platelets enable precision delivery
The approach relies on synthetic platelet technology developed by Anirban Sen Gupta, Wallace R. Persons professor of biomedical engineering, who patented it and licensed it to Haima Therapeutics, a biotech start-up he co-founded with CWRU alumna and COO Christa Pawlowski.
The technology, known as SynthoPlate, could have wider applications, including controlling life-threatening bleeding and targeted drug delivery.
Future clinical applications for different diseases
“Because the particle itself is a platform, you can load it with any drug, as long as you pick a disease or pathology where platelets can accumulate,” Sen Gupta said. “Really, it has potential for treating any disease that involves vascular injury and inflammation, from stroke and heart attack to autoimmune disorders like rheumatoid arthritis or infectious diseases like sepsis.”
Because the particle itself is a platform, you can load it with any drug.
Haima Therapeutics plans to begin human clinical trials of the platelet-inspired nanoparticles in 2027 and recently secured two Small Business Innovation Research Grants from the Defense Advanced Research Projects Agency (DARPA) to advance the technology towards clinical translation.
News
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
